X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE AJANTA PHARMA TTK HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 18.5 22.1 83.9% View Chart
P/BV x 4.7 4.2 111.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 TTK HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
AJANTA PHARMA
Mar-18
TTK HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs6631,818 36.5%   
Low Rs3991,106 36.1%   
Sales per share (Unadj.) Rs535.6239.5 223.7%  
Earnings per share (Unadj.) Rs15.952.8 30.2%  
Cash flow per share (Unadj.) Rs20.059.5 33.7%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.6230.0 59.8%  
Shares outstanding (eoy) m7.7788.77 8.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.06.1 16.2%   
Avg P/E ratio x33.327.7 120.3%  
P/CF ratio (eoy) x26.524.6 108.0%  
Price / Book Value ratio x3.96.4 60.7%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,127129,782 3.2%   
No. of employees `0001.76.8 25.1%   
Total wages/salary Rs m6073,765 16.1%   
Avg. sales/employee Rs Th2,436.73,128.4 77.9%   
Avg. wages/employee Rs Th355.2554.0 64.1%   
Avg. net profit/employee Rs Th72.5689.7 10.5%   
INCOME DATA
Net Sales Rs m4,16221,258 19.6%  
Other income Rs m61242 25.3%   
Total revenues Rs m4,22321,499 19.6%   
Gross profit Rs m1976,584 3.0%  
Depreciation Rs m32596 5.3%   
Interest Rs m304 729.3%   
Profit before tax Rs m1976,226 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,539 4.7%   
Profit after tax Rs m1244,686 2.6%  
Gross profit margin %4.731.0 15.3%  
Effective tax rate %37.024.7 149.7%   
Net profit margin %3.022.0 13.5%  
BALANCE SHEET DATA
Current assets Rs m1,62912,236 13.3%   
Current liabilities Rs m1,0583,461 30.6%   
Net working cap to sales %13.741.3 33.2%  
Current ratio x1.53.5 43.5%  
Inventory Days Days3060 49.5%  
Debtors Days Days3484 39.8%  
Net fixed assets Rs m55611,140 5.0%   
Share capital Rs m78177 43.9%   
"Free" reserves Rs m87820,237 4.3%   
Net worth Rs m1,06920,414 5.2%   
Long term debt Rs m15910 1,571.3%   
Total assets Rs m2,39924,486 9.8%  
Interest coverage x7.61,519.4 0.5%   
Debt to equity ratio x0.10 29,997.0%  
Sales to assets ratio x1.70.9 199.8%   
Return on assets %6.419.2 33.5%  
Return on equity %11.623.0 50.5%  
Return on capital %18.530.5 60.5%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3311,667 0.3%   
Fx outflow Rs m631,616 3.9%   
Net fx Rs m-3010,052 -0.3%   
CASH FLOW
From Operations Rs m1272,854 4.4%  
From Investments Rs m-146-2,604 5.6%  
From Financial Activity Rs m22-2 -1,095.0%  
Net Cashflow Rs m3248 1.0%  

Share Holding

Indian Promoters % 65.4 73.8 88.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 1.6 238.7%  
FIIs % 5.2 7.6 68.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.0 151.8%  
Shareholders   12,723 20,968 60.7%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  FULFORD INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS